NCT07015021
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Carfilzomib, +15 more
- Locations
-
Not specified
Clinical trial condition
Explore clinical trials studying Daratumumab. Study availability and eligibility vary by location and protocol.
NCT07015021
Not specified
NCT05835726